Search
Statistics
We have 222 registered usersThe newest registered user is raheelmemon
Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Combining Vitamin D to Fluoxetine for Major Depressive Disorder
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Combining Vitamin D to Fluoxetine for Major Depressive Disorder
Therapeutic Effects of Vitamin D as Adjunctive Therapy to Fluoxetine in Patients with Major Depressive Disorder
Source: Aust N Z J Psychiatry. 2012 Oct 23
Source: Aust N Z J Psychiatry. 2012 Oct 23
Objective: To compare the therapeutic effects of vitamin D(3) plus fluoxetine and fluoxetine alone in patients with major depressive disorder.
Methods:In the present double-blind, randomized, placebo-controlled trial, 42 patients with a diagnosis of major depressive disorder based on DSM-IV criteria were randomly assigned into two groups to receive daily either 1500 IU vitamin D(3) plus 20 mg fluoxetine or fluoxetine alone for 8 weeks. Depression severity was assessed at 2-week intervals using the 24-item Hamilton Depression Rating Scale (HDRS) as a primary outcome measure and the 21-item Beck Depression Inventory (BDI) as a secondary outcome measure. Serum 25(OH) vitamin D was measured at baseline and after intervention.
Results: Forty patients completed the trial. A two-way repeated-measures analysis of variance showed that depression severity based on HDRS and BDI decreased significantly after intervention, with a significant difference between the two groups. The vitamin D + fluoxetine combination was significantly better than fluoxetine alone from the fourth week of treatment.
Conclusions: In the present 8-week trial, the vitamin D + fluoxetine combination was superior to fluoxetine alone in controlling depressive symptoms.
Similar topics
» NEW: Fluoxetine 60 mg Tablets Available Now
» Which antidepressant is best option for major depressive disorder in children and adolescents
» Combining Risperidone and SSRIs (Benefit Vs Side Effects)
» JAMA: Rates of Major Depressive Disorder and Clinical Outcomes Following Traumatic Brain Injury
» Q. Medication for Bipolar I Disorder: Acute Hypomanic/Manic/Mixed Episodes Vs Acute Depressive Episode
» Which antidepressant is best option for major depressive disorder in children and adolescents
» Combining Risperidone and SSRIs (Benefit Vs Side Effects)
» JAMA: Rates of Major Depressive Disorder and Clinical Outcomes Following Traumatic Brain Injury
» Q. Medication for Bipolar I Disorder: Acute Hypomanic/Manic/Mixed Episodes Vs Acute Depressive Episode
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Sat Sep 10, 2016 1:45 pm by Admin
» L-Methylfolate: Who Will benefit
Sat Sep 03, 2016 3:00 pm by Admin
» Vitamins & Supplements in Clinical Practice.
Sun Aug 21, 2016 12:27 pm by Admin
» Imaging Biomarkers for Outcomes in Mild TBI
Fri Jul 22, 2016 12:37 pm by Admin
» Q.5 Clozapine Neutopenia
Mon Jul 11, 2016 8:43 pm by Admin
» Treating Disorders!
Mon Jul 04, 2016 1:52 am by troymackys
» Cortical Abnormalities in Adults & Adolescents with MDD
Sun Jul 03, 2016 12:59 pm by Admin
» Efficacy of Antipsychotics in Pediatric Acute Mania
Wed Jun 22, 2016 8:46 pm by Admin
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?
Tue Jun 21, 2016 9:34 pm by Admin